Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
This report describes the results of electroretinography in two siblings with CNGB3-associated achromatopsia.
|
28929832 |
2018 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
CTD_human |
Accessory heterozygous mutations in cone photoreceptor CNGA3 exacerbate CNG channel-associated retinopathy.
|
30418171 |
2018 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutation analysis revealed her to be homozygous for the common CNGB3 achromatopsia mutation, 1148delC (Thr383fs).
|
15161866 |
2004 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3.
|
12140185 |
2002 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in both subunits are associated with achromatopsia and progressive cone dystrophy, with mutations in CNGB3 alone accounting for 50% of all known cases of achromatopsia.
|
19767295 |
2009 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CNGA3 and CNGB3 are associated with achromatopsia, a rare autosomal recessive retinal disorder.
|
29499183 |
2018 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Transient photoreceptor deconstruction by CNTF enhances rAAV-mediated cone functional rescue in late stage CNGB3-achromatopsia.
|
23568263 |
2013 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Interestingly, subjects with GNAT2-associated ACHM had the greatest number of residual cones and the reflectivity of those cones was significantly greater than that of the cones in the subjects with CNGA3/CNGB3-associated ACHM.
|
25277229 |
2014 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Safety and Biodistribution Evaluation in CNGB3-Deficient Mice of rAAV2tYF-PR1.7-hCNGB3, a Recombinant AAV Vector for Treatment of Achromatopsia.
|
27003752 |
2016 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The patients presented with a clinical picture typical for congenital achromatopsia and there was no significant difference in the phenotype of subjects with either CNGA3 or CNGB3 mutations based on standard ophthalmological examination.
|
16319819 |
2005 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
Foveal cone structure showed little or no change in this group of subjects with CNGB3-associated achromatopsia.
|
28145975 |
2017 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
CNGB3 mutations cause a channelopathy that results in impaired cone function manifesting achromatopsia.
|
17652762 |
2007 |
Achromatopsia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
CNGB3 mutations account for 50% of all cases with autosomal recessive achromatopsia.
|
15657609 |
2005 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
An AAV vector expressing a human CNGB3 gene driven by the PR1.7 promoter rescued cone function in the mouse model of achromatopsia.
|
26603570 |
2016 |
Achromatopsia
|
0.800 |
Biomarker
|
disease |
BEFREE |
All three novel linked regions contain strong candidate genes, especially CNGB3 on 8q21.3, which has been shown to affect photoreceptors and cause complete color blindness.
|
30826882 |
2019 |
Achromatopsia
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
|
|
|
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Genetic testing revealed a common homozygous mutation in CNGB3 in 5 patients with complete achromatopsia and heterozygous mutations in CNGA3 in 2 patients with incomplete achromatopsia.
|
24676353 |
2014 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here, we present a comprehensive spectrum of CNGB3 mutations and their prevalence in a cohort of 1074 independent families clinically diagnosed with achromatopsia.
|
28795510 |
2017 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Recently, mutations in the gene encoding the CNGB3 subunit have been linked to achromatopsia in humans.
|
12815043 |
2003 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
The cone mosaics in eyes with CNGA3 and CNGB3 variants are severely disrupted; the cone mosaics in patients with GNAT2-associated ACHM; however, have been reported to show a contiguous pattern in adaptive optics (AO) retinal images.
|
27718025 |
2017 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Complete achromatopsia is genetically heterogeneous and segregates with mutations in CNGA3 or CNGB3 genes, which respectively encode for alpha- and beta-subunits of the cyclic-nucleotide-gated (CNG) cation channel expressed in cone photoreceptors.
|
12357335 |
2002 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Deep-intronic variants in CNGB3 cause achromatopsia by pseudoexon activation.
|
31544997 |
2020 |
Achromatopsia
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Mutations in CNGA3 and CNGB3, the genes encoding the subunits of the tetrameric cone photoreceptor cyclic nucleotide-gated ion channel, cause achromatopsia, a congenital retinal disorder characterized by loss of cone function.
|
30418171 |
2018 |
Achromatopsia
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
CNGB3 mutation spectrum including copy number variations in 552 achromatopsia patients.
|
28795510 |
2017 |